It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Pathophysiological roles of cardiac dopamine system remain unknown. Here, we show the role of dopamine D1 receptor (D1R)-expressing cardiomyocytes (CMs) in triggering heart failure-associated ventricular arrhythmia. Comprehensive single-cell resolution analysis identifies the presence of D1R-expressing CMs in both heart failure model mice and in heart failure patients with sustained ventricular tachycardia. Overexpression of D1R in CMs disturbs normal calcium handling while CM-specific deletion of D1R ameliorates heart failure-associated ventricular arrhythmia. Thus, cardiac D1R has the potential to become a therapeutic target for preventing heart failure-associated ventricular arrhythmia.
The pathophysiological role of dopamine D1 receptor (D1R) in chronic heart failure remains elusive. Here the authors show that D1R-expressing cardiomyocytes appear in chronic heart failure and play a pivotal role in triggering lethal ventricular arrhythmias.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Graduate School of Medicine, The University of Tokyo, Department of Cardiovascular Medicine, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
2 Graduate School of Medicine, The University of Tokyo, Department of Cardiovascular Medicine, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X); Yale School of Medicine, Department of Neurology and Immunobiology, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710)
3 Graduate School of Medicine, The University of Tokyo, Department of Cardiovascular Medicine, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X); The University of Tokyo, Genome Science Division, Research Center for Advanced Science and Technologies, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
4 The University of Tokyo, Genome Science Division, Research Center for Advanced Science and Technologies, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X); Chiba University Graduate School of Medicine, Department of Cardiovascular Medicine, Chiba, Japan (GRID:grid.136304.3) (ISNI:0000 0004 0370 1101)
5 Osaka University Graduate School of Medicine, Department of Cardiovascular Medicine, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971)
6 University of Colorado, Human Medical Genetics and Genomics, Boulder, USA (GRID:grid.266190.a) (ISNI:0000000096214564)
7 Iwate Medical University, Department of Pharmacotherapeutics, School of Pharmacy, Morioka, Japan (GRID:grid.411790.a) (ISNI:0000 0000 9613 6383)
8 Juntendo University Graduate School of Medicine, Department of Neurophysiology, Tokyo, Japan (GRID:grid.258269.2) (ISNI:0000 0004 1762 2738)
9 Graduate School of Medicine, Chiba University, Department of Disease Biology and Molecular Medicine, Chiba, Japan (GRID:grid.136304.3) (ISNI:0000 0004 0370 1101)
10 Brain Research Institute, Niigata University, Department of Comparative and Experimental Medicine, Niigata, Japan (GRID:grid.260975.f) (ISNI:0000 0001 0671 5144)
11 University of Colorado, Human Medical Genetics and Genomics, Boulder, USA (GRID:grid.266190.a) (ISNI:0000000096214564); University of Colorado, Cardiovascular Institute and Adult Medical Genetics Program, Boulder, USA (GRID:grid.266190.a) (ISNI:0000000096214564)
12 Graduate School of Medicine, The University of Tokyo, Department of Cardiovascular Medicine, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X); The University of Tokyo, Department of Advanced Translational Research and Medicine in Management of Pulmonary Hypertension, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
13 Toho University, Department of Physiology, Faculty of Medicine, Tokyo, Japan (GRID:grid.265050.4) (ISNI:0000 0000 9290 9879)